Insights

Acquired by Arkis BioSciences was acquired by Integra LifeSciences in 2019, suggesting a potential path for channel partnerships, integration opportunities, or joint marketing initiatives with a larger medical device ecosystem.

Clinical heritage With a focus on safer, less invasive intracranial procedures and specialized shunt solutions,ArkIs offers products like Endexo technology and CerebroFlo EVD Catheters that may complement or expand the product offerings of neurosurgery device distributors and hospital procurement channels.

Early stage funding Historical funding from Innova Memphis and angel groups indicates institutional interest in neurovascular innovation, signaling opportunities to engage potential co-development partners, venture-backed buyers, or strategic investors evaluating new neurosurgical tech bets.

Small team scale With 11-50 employees and <$1M revenue, Arkis presents as a nimble target for pilot deployments, reusable technology trials, and enterprise procurement pilots within hospital systems seeking innovative, less invasive solutions.

Tech and web Current tech stack suggests standard modern web presence; potential upsell to digital onboarding, customer training portals, or data analytics integrations aligned with implantable device ecosystems and post-market surveillance.

Similar companies to Arkis BioSciences

Arkis BioSciences Tech Stack

Arkis BioSciences uses 8 technology products and services including Drupal, WordPress, Microsoft 365, and more. Explore Arkis BioSciences's tech stack below.

  • Content Management System
  • Content Management System
  • jQuery
    Javascript Libraries
  • PHP
    Programming Languages
  • Yoast SEO
    Search Engines
  • Bootstrap
    UI Frameworks
  • Google Analytics
    Web Analytics

Arkis BioSciences's Email Address Formats

Arkis BioSciences uses at least 3 email formats:
Arkis BioSciences Email FormatsExamplePercentage
FLast@arkisbiosciences.comJDoe@arkisbiosciences.com
50%
First@arkisbiosciences.comJohn@arkisbiosciences.com
38%
First.Last@arkisbiosciences.comJohn.Doe@arkisbiosciences.com
12%

Frequently Asked Questions

What is Arkis BioSciences's phone number?

Minus sign iconPlus sign icon
You can contact Arkis BioSciences's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Arkis BioSciences's official website and social media links?

Minus sign iconPlus sign icon
Arkis BioSciences's official website is arkisbiosciences.com and has social profiles on LinkedIn.

How much revenue does Arkis BioSciences generate?

Minus sign iconPlus sign icon
As of July 2026, Arkis BioSciences's annual revenue is estimated to be <$1M.

What is Arkis BioSciences's SIC code and NAICS code?

Minus sign iconPlus sign icon
Arkis BioSciences's SIC code is 8733 - Noncommercial Research Organizations and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Arkis BioSciences have currently?

Minus sign iconPlus sign icon
As of July 2026, Arkis BioSciences has approximately 13 employees across 1 continents, including North America. Key team members include Electrical Engineering Intern: A. W. Explore Arkis BioSciences's employee directory with LeadIQ.

What industry does Arkis BioSciences belong to?

Minus sign iconPlus sign icon
Arkis BioSciences operates in the Biotechnology industry.

What technology does Arkis BioSciences use?

Minus sign iconPlus sign icon
Arkis BioSciences's tech stack includes Drupal, WordPress, Microsoft 365, jQuery, PHP, Yoast SEO, Bootstrap and Google Analytics.

What is Arkis BioSciences's email format?

Minus sign iconPlus sign icon
Arkis BioSciences's email format typically follows the pattern of FLast@arkisbiosciences.com. Find more Arkis BioSciences email formats with LeadIQ.

How much funding has Arkis BioSciences raised to date?

Minus sign iconPlus sign icon
As of July 2026, Arkis BioSciences has raised $9.6M in funding. The last funding round occurred on Feb 26, 2019.
Arkis BioSciences logo

Arkis BioSciences

BiotechnologyTennessee, United States11-50 Employees

Arkis BioSciences is a biotechnology research company focused on therapies for intracranial hypertension, including hydrocephalus and related disorders. It develops a range of medical devices, from surgical instruments to implantable technologies, intended to enable safer and less invasive surgeries and to offer improved shunt options for personalized treatment. Its target customers are neurosurgical teams and healthcare facilities that manage intracranial pressure conditions, with the aim of improving patient outcomes. Founded in 2013 by a neurosurgeon, a former engineering patent examiner, and a business developer, Arkis is based in Knoxville, Tennessee. The company operates with a small to mid-sized team within the biotechnology research landscape, pursuing solutions for intracranial pressure management and related disorders.

Section iconCompany Overview

Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
11-50

Section iconFunding & Financials

  • $9.6M

    Arkis BioSciences has raised a total of $9.6M of funding over 7 rounds. Their latest funding round was raised on Feb 26, 2019 as a Convertible Note.

  • <$1M

    Arkis BioSciences's revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.